Are your or a loved one experiencing the symptoms of Alzheimer's Disease?
Segal Institute for Clinical Research is currently conducting an outpatient clinical research study evaluating the safety and efficacy of an investigation medication for individuals between the ages of 50-85 diagnosed or experiencing the symptoms of Alzheimer's Disease.
Volunteers May Qualify if they are:
- Between the ages of 50-85 years old
- Experiencing/diagnosed with Alzheimer's Disease
- Have a legal guardian or representative to track drug administration